HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo

BACKGROUND: The presence of CAR in diverse tumor types is heterogeneous with implications in tumor transduction efficiency in the context of adenoviral mediated cancer gene therapy. Preliminary studies suggest that CAR transcriptional regulation is modulated through histone acetylation and not throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Segura-Pacheco, Blanca, Avalos, Berenice, Rangel, Edgar, Velazquez, Dora, Cabrera, Gustavo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174455/
https://www.ncbi.nlm.nih.gov/pubmed/17892546
http://dx.doi.org/10.1186/1479-0556-5-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174455/
https://www.ncbi.nlm.nih.gov/pubmed/17892546
http://dx.doi.org/10.1186/1479-0556-5-10

Ejemplares similares